Himastatin Derivatives Synthesis via Silver(I)-Promoted Oxidative Dimerization
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current synthetic strategies for (−)-himastatin face challenges in forming the critical C5-C5′ biaryl linkage, leading to reduced antibiotic activity, and existing methods are inefficient in evading bacterial resistance mechanisms.
Innovation Solution
A concise total synthesis is achieved through a biomimetic final-stage dimerization using a silver(I)-promoted oxidative dimerization reaction, forming the central C5-C5′ biaryl linkage via a radical-radical coupling pathway, enabling the preparation of dimeric cyclotryptophans and indolines, and introducing structural modifications to enhance bioactivity and resistance evasion.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If early-stage Stille coupling is used to form the central C5-C5′ linkage, then the biaryl linkage can be formed, but the antibiotic activity is reduced
Solution Approach 1:
The patent performs the dimerization coupling reaction at the final stage of synthesis rather than early stage, allowing the macrocyclic core to be fully formed first. This preliminary formation of the active macrocyclic structure before dimerization preserves antibiotic activity while enabling efficient synthesis through convergent assembly of pre-formed monomer units
Solution Approach 2:
The patent changes the timing parameter of the coupling reaction from early-stage to final-stage in the synthetic sequence. This parameter change transforms the synthesis from a linear early-dimerization approach to a convergent final-dimerization approach, maintaining antibiotic activity while improving overall synthetic efficiency through better yield accumulation
2Reliability
If late-stage dimerization via cross-coupling is attempted, then the C5-C5′ linkage can be formed, but the reaction is unsuccessful
Solution Approach 1:
The patent changes the chemical parameter of the coupling reaction by selecting oxidative dimerization conditions with silver(I) catalyst and oxidant instead of traditional cross-coupling methods. This parameter change enables successful late-stage dimerization of the macrocyclic monomers to form the C5-C5′ biaryl linkage with high reliability
Solution Approach 2:
The patent introduces silver(I) as a catalyst intermediary and oxidant as a mediator to facilitate the dimerization reaction. These intermediaries enable the coupling reaction to proceed successfully at the final stage by mediating the formation of the C5-C5′ linkage between macrocyclic monomers without requiring complex synthetic maneuvers
3Ease of manufacture
If monomeric derivatives are synthesized, then the synthesis is simpler, but the antibiotic activity is reduced
Solution Approach 1:
The patent synthesizes monomeric macrocyclic units with all necessary functional groups and stereochemistry pre-formed, then dimerizes them at the final stage. This preliminary formation of active monomer units simplifies the synthesis of each individual component while the subsequent dimerization restores the full antibiotic activity required for biological function
Solution Approach 2:
The patent segments the himastatin molecule into two identical macrocyclic monomer units that can be synthesized independently and then coupled. This segmentation allows simpler synthesis of individual monomers while maintaining the ability to form the active dimeric structure through final-stage coupling, thus preserving antibiotic activity
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for the production of himastatin derivatives with improved bioactivity and resistance evasion capabilities, effectively targeting and disrupting bacterial membranes, while maintaining potency against multi-drug resistant bacteria.
Implementation Method 1
a newly developed silver(I)-promoted oxidative dimerization reaction to secure the central C5-C5′ biaryl linkage
Implementation Method 2
forming the central C5-C5′ biaryl linkage via a radical-radical coupling pathway
Data Source
AI summary
The present disclosure provides compounds of Formula I, methods of preparing the compounds, compositions, kits, and methods of using the compounds for treating or preventing microbial infections.